13-15 Mojsov believes that this creates an ideal opportunity for industry-academia collaborations, allowing pharmaceutical researchers to observe drug effects in clinical trials while basic scientists investigate the underlying mechanisms
Who Should Consider GLP-1 Therapy FDA indications for weight loss require: BMI 30 (obesity), or BMI 27 (overweight) with at least one weight-related condition hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, or similar These thresholds set eligibility, but they don't answer the more important question: who benefits most
And so I'll give a simple thing about the IVs first because when I was, I used to be one of the company pharmacy in the United States where I used to make all the IV-glutathione and even though we knew this was not the best option, that's the only option we had to get inside your bloodstream
Cell Communication and Signaling Research by Julianna Kardos et al., published in Cell Communication and Signaling
